Pancreatic Cancer Research

ResearcherUniversity of California, San FranciscoActive in the last 2 years

Morgan Bonds

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5342-7911; OpenAlex author ID A5028894069. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
51
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 2 papers · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 7

  1. Advances in Imaging of Pancreatic Adenocarcinoma. First author DOI 10.1016/j.soc.2025.03.003↗
  2. Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX. Co-author DOI 10.1001/jamaoncol.2024.5917↗
  3. Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX. Co-author DOI 10.1097/sla.0000000000006650↗
  4. Innovative Imaging Techniques Used to Evaluate Borderline-Resectable Pancreatic Adenocarcinoma. First author DOI 10.1016/j.jss.2022.10.008↗
  5. Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study. Co-author DOI 10.1245/s10434-022-12387-2↗
  6. Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment. Co-author DOI 10.1001/jamaoncol.2020.3537↗
  7. Contemporary Review of Borderline Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/jcm8081205↗

Closest collaborators

The 25 strongest of 51 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Isabel S. Dennahy · 2 shared papers, 2023–2026 · strength 0.81
  2. Giuseppe Malleo · 2 shared papers, 2020–2025 · strength 0.22
  3. Alberto Balduzzi · 2 shared papers, 2020–2025 · strength 0.22
  4. Tobias Keck · 2 shared papers, 2020–2025 · strength 0.22
  5. Asif Halimi · 2 shared papers, 2020–2025 · strength 0.22
  6. Adnan A. Alseidi · 2 shared papers, 2020–2025 · strength 0.22
  7. Daniel Pietrasz · 2 shared papers, 2020–2025 · strength 0.22
  8. Johan Gagnière · 2 shared papers, 2020–2025 · strength 0.22
  9. Stijn R. van Roessel · 2 shared papers, 2020–2025 · strength 0.22
  10. Frederik Christiaan Berrevoet · 2 shared papers, 2020–2025 · strength 0.22
  11. Kevin C. Conlon · 2 shared papers, 2020–2025 · strength 0.22
  12. Eran van Veldhuisen · 2 shared papers, 2020–2025 · strength 0.22
  13. Thilo Hackert · 2 shared papers, 2020–2025 · strength 0.22
  14. Isabella M. Frigerio · 2 shared papers, 2020–2025 · strength 0.22
  15. Giovanni Butturini · 2 shared papers, 2020–2025 · strength 0.22
  16. Quisette P. Janssen · 2 shared papers, 2020–2025 · strength 0.22
  17. Hanneke W.M. van Laarhoven · 2 shared papers, 2020–2025 · strength 0.22
  18. Keith John Roberts · 2 shared papers, 2020–2025 · strength 0.22
  19. Bas Groot Koerkamp · 2 shared papers, 2020–2025 · strength 0.22
  20. Oonagh M. Griffin · 2 shared papers, 2020–2025 · strength 0.22
  21. Rupaly Pandé · 2 shared papers, 2020–2025 · strength 0.22
  22. Mickaël Lesurtel · 2 shared papers, 2020–2025 · strength 0.22
  23. António Sá Cunha · 2 shared papers, 2020–2025 · strength 0.22
  24. Gianpaolo Balzano · 2 shared papers, 2020–2025 · strength 0.22
  25. Marc G. Besselink · 2 shared papers, 2020–2025 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.